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Background
•
•

Variation in antibiotic use is described within several
common conditions and is associated with antibiotic
overuse
A broader understanding of antibiotic variation, using
an antibiotic-focused approach, can inform
stewardship efforts

Objective
• To develop a novel assessment of antibiotic variation,
based on the breadth of conditions an antibiotic is used
for, as well as overall antibiotic use, measured by days
of therapy (DOT)

Methods
• Antibiotic use was assessed among hospitalized
patients 60d-18y in 2019 using PHIS
• Common antibiotics were identified as those which
accounted for > 1% total DOT at >80% of hospitals
• An antibiotic’s DOT and number of associated conditions
were used to develop an Antibiotic Diversity Index (ADI)
for each antibiotic at each hospital
• ADI derivation was based on the Shannon-Weiner
entropy index, a conceptual model used in ecology to
measure complexity of ecosystems
• Clinically, an antibiotic’s ADI reflects the breadth of
conditions an antibiotic is used for as well as intensity of
antibiotic use
• Hospital-level variation in antibiotic use patterns were
measured by the spread of an antibiotic’s ADIs across
hospitals relative to its mean ADI (ADI coefficient of
variation).

Results

Figure 2. Cefazolin use by hospital and conditions

Table 1. Most commonly-used antibiotics and associated metrics at
49 children’s hospitals
Mean
Antibiotic
ADI
ADI CV
Meropenem
39.3
43.2
Piperacillin/tazobactam
30.8
41.8
Cefepime HCl
66.8
35.1
Ampicillin sod/sulbactam
57
34.6
Ampicillin
62.1
34
Sulfamethoxazole/trimeth
36.5
33.1
Metronidazole
79.9
32.6
Azithromycin
59.5
29.3
Clindamycin
45.4
27.2
Amoxicillin trihydrate
87.5
26.9
Amox trihydrate/K clavul
60
23
Vancomycin
76.3
22.9
Ceftriaxone sodium
106.4
19.2
Cefazolin sodium
15
113.8
*Median number of conditions as described by 3M All Patient Refined Diagnosis
Related Groups (APR-DRG); ADI= antibiotic diversity index; CV= coefficient of
variation

Figure 1. Meropenem use by hospital and conditions

. the mean ADI and ADI Coefficient of Variation
• Table 1 shows
(CV) for each commonly used antibiotic
• Antibiotics with a larger ADI are used across a larger, vast
number of conditions
• Antibiotics with a larger CV are those with wide hospital-level
variation in antibiotic use
• Figures 1 and 2 exemplify ADI application in stewardship
1. Meropenem has a relatively small ADI and is used more
rarely across fewer conditions. It has the largest CV,
denoting its use is highly varied across hospitals and
conditions.
2. Cefazolin has the highest mean ADI and is used across a
wide breadth of conditions. It also has the smallest CV,
denoting similar patterns of use across hospitals and
conditions.

Conclusions
• ADI is a novel tool to measure variability in antibiotic use
across hospitals
• Comparisons of ADIs highlight antibiotics associated with
unequal patterns of use and their associated conditions

